Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gaby Bolton & Anton Isaacs. (2018) Women’s experiences of cancer-related cognitive impairment, its impact on daily life and care received for it following treatment for breast cancer. Psychology, Health & Medicine 23:10, pages 1261-1274.
Read now
Read now
Theresa A Koleck & Yvette P Conley. (2016) Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level. Breast Cancer: Targets and Therapy 8, pages 29-37.
Read now
Read now
Articles from other publishers (28)
Tahnee L. Downs, Eliza J. Whiteside, Gaye Foot, Dean E. Mills & Edward S. Bliss. (2023) Differences in total cognition and cerebrovascular function in female breast cancer survivors and cancer-free women. The Breast 69, pages 358-365.
Crossref
Crossref
Firat Kara, Christine M. Lohse, Anna M. Castillo, Nirubol Tosakulwong, Timothy G. Lesnick, Clifford R. JackJrJr, Ronald C. Petersen, Janet E. Olson, Fergus J. Couch, Kathryn J. Ruddy, Kejal Kantarci & Michelle M. Mielke. (2022)
Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain
MRI
markers of neurodegeneration
. Cancer Medicine 12:3, pages 2805-2817.
Crossref
Crossref
Steven Jett, Niharika Malviya, Eva Schelbaum, Grace Jang, Eva Jahan, Katherine Clancy, Hollie Hristov, Silky Pahlajani, Kellyann Niotis, Susan Loeb-Zeitlin, Yelena Havryliuk, Richard Isaacson, Roberta Diaz Brinton & Lisa Mosconi. (2022) Endogenous and Exogenous Estrogen Exposures: How Women’s Reproductive Health Can Drive Brain Aging and Inform Alzheimer’s Prevention. Frontiers in Aging Neuroscience 14.
Crossref
Crossref
Lucy R. Haggstrom, Janette L. Vardy, Emma-Kate Carson, Davendra Segara, Elgene Lim & Belinda E. Kiely. (2022) Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review. Cancers 14:4, pages 920.
Crossref
Crossref
Renáta Androvičová, James G. Pfaus & Saak V. Ovsepian. (2021) Estrogen pendulum in schizophrenia and Alzheimer’s disease: Review of therapeutic benefits and outstanding questions. Neuroscience Letters 759, pages 136038.
Crossref
Crossref
Fatima Jebahi, Saryu Sharma, Jamie E. Bloss & Heather H. Wright. (2021) Effects of tamoxifen on cognition and language in women with breast cancer: A systematic search and a scoping review. Psycho-Oncology 30:8, pages 1262-1277.
Crossref
Crossref
Gianfranco Natale & Guido Bocci. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics
1
25
.
Gianfranco Natale & Guido Bocci. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
765
789
.
Helena Carreira, Rachael Williams, Martin Müller, Rhea Harewood, Susannah Stanway & Krishnan Bhaskaran. (2018) Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review. JNCI: Journal of the National Cancer Institute 110:12, pages 1311-1327.
Crossref
Crossref
E. A. Underwood, P. A. Rochon, R. Moineddin, P. E. Lee, W. Wu, K. I. Pritchard & M. C. Tierney. (2017) Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Research and Treatment 168:2, pages 299-310.
Crossref
Crossref
Emilie Le Rhun, Sophie Taillibert & Marc C. Chamberlain. 2018. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
435
469
.
Jeffrey D. Blaustein. (2017) Treatments for Breast Cancer That Affect Cognitive Function in Postmenopausal Women. Policy Insights from the Behavioral and Brain Sciences 4:2, pages 170-177.
Crossref
Crossref
Bok Yae ChungEun Hee ChoiGyung Duck KimKyung Hae KimHye Sun Byun. (2017) Development of the Cognitive Function Scale for Breast Cancer Patients. Asian Oncology Nursing 17:1, pages 12.
Crossref
Crossref
Cuicui Li, Chenglin Zhou & Rena Li. (2015) Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?. Molecular Neurobiology 53:6, pages 4238-4246.
Crossref
Crossref
Philip E. Lee, Mary C. Tierney, Wei Wu, Kathleen I. Pritchard & Paula A. Rochon. (2016) Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies. Breast Cancer Research and Treatment 158:3, pages 407-420.
Crossref
Crossref
Ioannis Bakoyiannis, Eleousa-Alexandra Tsigka, Despina Perrea & Vasilios Pergialiotis. (2015) The Impact of Endocrine Therapy on Cognitive Functions of Breast Cancer Patients: A Systematic Review. Clinical Drug Investigation 36:2, pages 109-118.
Crossref
Crossref
Wilbert Zwart, Huub Terra, Sabine C. Linn & Sanne B. Schagen. (2015) Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?. Nature Reviews Clinical Oncology 12:10, pages 597-606.
Crossref
Crossref
Nicole Sabaliauskas, Hui Shen, Jonela Molla, Qi Hua Gong, Aarti Kuver, Chiye Aoki & Sheryl S. Smith. (2015) Neurosteroid effects at α4βδ GABA A receptors alter spatial learning and synaptic plasticity in CA1 hippocampus across the estrous cycle of the mouse. Brain Research 1621, pages 170-186.
Crossref
Crossref
R. Vierk, J. Bayer, S. Freitag, M. Muhia, K. Kutsche, T. Wolbers, M. Kneussel, T. Sommer & G.M. Rune. (2015) Structure–function–behavior relationship in estrogen-induced synaptic plasticity. Hormones and Behavior 74, pages 139-148.
Crossref
Crossref
Emilie Le Rhun, Xavier Delbeuck, Claudia Lefeuvre-Plesse, Andrew Kramar, Emilie Skrobala, Florence Pasquier & Jacques Bonneterre. (2015) A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy. Breast Cancer Research and Treatment 152:3, pages 569-580.
Crossref
Crossref
Catherine M. Bender, John D. Merriman, Amanda L. Gentry, Gretchen M. Ahrendt, Sarah L. Berga, Adam M. Brufsky, Frances E. Casillo, Meredith M. Dailey, Kirk I. Erickson, Frances M. Kratofil, Priscilla F. McAuliffe, Margaret Q. Rosenzweig, Christopher M. Ryan & Susan M. Sereika. (2015) Patterns of change in cognitive function with anastrozole therapy. Cancer 121:15, pages 2627-2636.
Crossref
Crossref
Florien W. Boele, Christina M.T. Schilder, Mari-Lou de Roode, Jan Berend Deijen & Sanne B. Schagen. (2015) Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer. Menopause 22:1, pages 17-25.
Crossref
Crossref
Bauke Buwalda & Sanne B. Schagen. (2013) Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?. Life Sciences 93:17, pages 581-588.
Crossref
Crossref
Gyung Duck KimBok Yae ChungKyung Hae KimHye Sun ByunEun Hee Choi. (2013) Comparison of Climacteric Symptoms and Cognitive Impairment in Breast Cancer Survivors and Healthy Women. Asian Oncology Nursing 13:1, pages 11.
Crossref
Crossref
Angela S. PecheninoAlison R. LeeLi LinFiona N. Mbai, John N. Stallone & A. A. Knowlton. (2012) Reply to “Letter to the Editor: ‘Understanding the WHI gap’”. Physiological Genomics 44:5, pages 330-330.
Crossref
Crossref
Lisa Lejbak, Margaret Crossley & Mirna Vrbancic. (2011) A male advantage for spatial and object but not verbal working memory using the n-back task. Brain and Cognition 76:1, pages 191-196.
Crossref
Crossref
Susan F. Dent, Rania Gaspo, Michelle Kissner & Kathleen I. Pritchard. (2011) Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Research and Treatment 126:2, pages 295-310.
Crossref
Crossref
Kunal Agrawal, Susan Onami, Joanne E. Mortimer & Sumanta Kumar Pal. (2010) Cognitive changes associated with endocrine therapy for breast cancer. Maturitas 67:3, pages 209-214.
Crossref
Crossref